SEVERE WX : Air Stagnation Advisory View Alerts

FDA authorizes emergency use of the antibody cocktail given to Trump to treat Covid-19

The US Food and Drug Administration on Saturday issued an...

Posted: Nov 21, 2020 8:55 PM

The US Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron's antibody cocktail to treat Covid-19 in high-risk patients with mild to moderate disease.

President Donald Trump received the therapy, called REGEN-COV2, when he was hospitalized for coronavirus. The treatment has to be infused into the bloodstream and is meant to mimic an immune response to infection.

The cocktail reduced Covid-19-related hospitalizations and emergency room visits in some patients within 28 days of treatment, the FDA said in a news release.

Regeneron's chief executive officer, Dr. Leonard S. Schleifer, said in a statement that demand may initially exceed supply, "making it even more critical that federal and state governments ensure REGEN-COV2 is distributed fairly and equitably to the patients most in need."

An emergency use authorization (EUA) is a lower regulatory bar than full approval by the FDA. An EUA allows products to be used under particular circumstances before all the evidence is available for approval.

"When used to treat COVID-19 for the authorized population, the known and potential benefits of these antibodies outweigh the known and potential risks," the FDA said.

Regeneron submitted its application for the authorization in October, shortly after Trump tested positive for the coronavirus and received the biotechnology company's antibody therapy.

"Regeneron now expects to have REGEN-COV2 treatment doses ready for approximately 80,000 patients by the end of November, approximately 200,000 patients by the first week of January, and approximately 300,000 patients in total by the end of January 2021," the company said in a news release Saturday.

Treatment is for use early in infection

Unlike some other drugs used for Covid-19, the antibody cocktail is meant to be given early in infection, before patients are hospitalized or require oxygen therapy. The drug should be given as soon as possible after a positive viral test, according to the FDA.

The FDA's authorization is limited to high-risk patients, like those who are older than 65 years of age or have a BMI greater than or equal to 35. Patients with other conditions like diabetes, cardiovascular disease or chronic kidney disease also qualify for the drug.

The authorization only applies to patients 12 years of age or older. The cocktail has not been authorized for use in patients who are hospitalized with Covid-19 or need oxygen therapy because of Covid-19.

Regeneron's cocktail is a combination of two monoclonal antibodies, casirivimab and imdevimab, that are produced in a laboratory.

The antibodies target the spike protein the virus uses to drill into healthy cells. With two antibodies, the hope is to trap and shut down viral replication.

"The FDA remains committed to advancing the nation's public health during this unprecedented pandemic. Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system," said FDA Commissioner Dr. Stephen Hahn in a statement.

Regeneron isn't the only company that's been working on antibody therapies for the coronavirus. There are more than 70 different antibody treatments for Covid-19 under investigation, according to BIO, an association that represents major biotechnology companies

Earlier this month, the FDA issued an emergency use authorization for another antibody treatment from pharmaceutical manufacturer Eli Lilly with similar conditions.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 70832

Reported Deaths: 885
CountyCasesDeaths
Multnomah15875232
Washington997499
Marion9017137
Clackamas585377
Umatilla430149
Lane420241
Jackson364428
Malheur237942
Deschutes222814
Yamhill164816
Linn138522
Polk116816
Douglas91217
Jefferson80811
Union7715
Benton7667
Klamath7604
Morrow6517
Lincoln61315
Wasco51919
Josephine5104
Columbia4783
Coos4182
Hood River3941
Clatsop3510
Baker2723
Crook2176
Grant1341
Curry1292
Tillamook1230
Lake1171
Harney961
Wallowa713
Sherman230
Gilliam220
Wheeler30
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 1185576

Reported Deaths: 19089
CountyCasesDeaths
Los Angeles3877937604
San Bernardino902221129
Riverside857741437
San Diego76359996
Orange750951577
Kern40337448
Fresno37724481
Sacramento35854566
Santa Clara32985476
Alameda28857505
San Joaquin25738502
Contra Costa23571261
Stanislaus21460424
Tulare20649308
Ventura19058175
Imperial15862356
San Francisco15156160
Monterey14750116
San Mateo13715170
Sonoma11922157
Merced11537179
Santa Barbara11277135
Kings1047587
Solano1003681
Marin7628129
Placer635468
Madera604785
San Luis Obispo596435
Shasta471847
Yolo462675
Santa Cruz426928
Butte389459
Sutter314415
Napa298817
El Dorado22174
Yuba198110
San Benito183716
Lassen17733
Tehama161225
Mendocino148522
Nevada11849
Tuolumne9088
Glenn8928
Lake89019
Humboldt8509
Colusa6946
Siskiyou6242
Mono5273
Amador52016
Calaveras47822
Del Norte3131
Inyo29016
Plumas2050
Trinity1390
Mariposa1282
Modoc1250
Alpine470
Sierra190
Unassigned00
Medford
Overcast
35° wxIcon
Hi: 48° Lo: 30°
Feels Like: 35°
Brookings
Clear
53° wxIcon
Hi: 52° Lo: 40°
Feels Like: 53°
Crater Lake
Clear
40° wxIcon
Hi: 41° Lo: 23°
Feels Like: 34°
Grants Pass
Overcast
36° wxIcon
Hi: 45° Lo: 29°
Feels Like: 36°
Klamath Falls
Clear
40° wxIcon
Hi: 43° Lo: 19°
Feels Like: 34°
Foggy Saturday morning with afternoon clouds
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events